Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-03-12Clinical Trial Update: Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 3]
Phase 3 trial update comparing olaparib alone or the combination of cediranib plus olaparib against standard chemotherapy in platinum-sensit…
-
CLINICAL_TRIALS trial_result · 2021-03-12Clinical Trial Update: Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 3]
A phase 3 trial compares olaparib alone or the combination of cediranib and olaparib versus standard chemotherapy for women with platinum-se…
-
CLINICAL_TRIALS trial_result · 2021-02-25Clinical Trial Update: A Randomized Study of Safety and Efficacy of Pazopanib and Gemcitabine in Persistent or Relapsed Ovarian Cancer [Phase 2]
Phase 2 randomized study evaluating safety and efficacy of Pazopanib plus Gemcitabine in persistent or relapsed ovarian cancer (and related …
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: NUC-1031 in Patients With Platinum-Resistant Ovarian Cancer [Phase 2]
Phase 2 trial update for NUC-1031 in platinum-resistant ovarian cancer; study terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2021-02-17Clinical Trial Update: First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Mirvetuximab Soravtansine in Adults With Ovarian Cancer and Other Folate Receptor 1 (FOLR1)-Positive Solid Tumors [Phase 1]
Phase 1 first-in-human study evaluating mirvetuximab soravtansine in adults with ovarian cancer and other FOLR1-positive solid tumors; study…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations [Phase 1, Phase 2]
Pilot trial of BMN 673 (olaparib) in advanced solid tumors with deleterious BRCA mutations completed phases 1 and 2; results posted.
-
CLINICAL_TRIALS trial_result · 2021-01-27Clinical Trial Update: Pilot Study of Durvalumab and Vigil in Advanced Women's Cancers [Phase 2]
Phase 2 pilot study evaluating durvalumab with Vigil in advanced women's cancers has completed.
-
CLINICAL_TRIALS trial_result · 2021-01-26Clinical Trial Update: Safety and Tolerability of a Modified Vaccinia Ankara (MVA)-Based Vaccine Modified to Express Brachyury and T-cell Costimulatory Molecules (MVA-Brachyury-TRICOM) [Phase 1]
Phase 1 trial evaluating safety and tolerability of an MVA-based vaccine expressing brachyury and T-cell costimulatory molecules (MVA-Brachy…
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: Letrozole Combined With Anlotinib Hydrochloride in the Treatment of Platinum-resistant Recurrent Ovarian Cancer [Phase 2]
A Phase 2 clinical trial evaluating letrozole combined with anlotinib hydrochloride for platinum-resistant recurrent ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2021-01-20Clinical Trial Update: Compare Fallopian Tube Cells Collected by Cytuity With Removed Ovarian/Tubal Tissue to Determine Presence of Malignancy
Clinical trial evaluating whether fallopian tube cells collected by Cytuity can determine the presence of malignancy compared with removed o…
-
CLINICAL_TRIALS trial_result · 2020-12-28Clinical Trial Update: Efficacy Study of CPC634 (CriPec® Docetaxel) in Platinum Resistant Ovarian Cancer [Phase 2]
Phase 2 trial update for CPC634 (CriPec Docetaxel) in platinum-resistant ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-12-19Clinical Trial Update: Evaluation of Enzastaurin in the Treatment of Persistent or Recurrent Ovarian or Primary Peritoneal Cancer [Phase 2]
Phase 2 clinical trial evaluating enzastaurin for persistent or recurrent ovarian or primary peritoneal cancer has completed with results po…
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer [Phase 3]
A Phase 3 trial comparing patupilone to doxorubicin in ovarian, fallopian tube, or peritoneal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-12-14Clinical Trial Update: Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer [Phase 3]
This Phase 3 trial evaluates whether adding bevacizumab to a carboplatin, paclitaxel, and gemcitabine regimen after surgery improves outcome…
-
CLINICAL_TRIALS trial_result · 2020-12-10Clinical Trial Update: Efficacy and Safety of Paclitaxel (Albumin-bound) Combination With Carboplatin in Ovarian Cancer. [Phase 2]
Phase 2 trial update on paclitaxel-albumin bound with carboplatin for ovarian cancer report focusing on efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2020-12-08Clinical Trial Update: Masitinib in Combination With Gemcitabine in Advanced/Metastatic Epithelial Ovarian Cancer Patients [Phase 2, Phase 3]
Phase 2/3 trial update for masitinib in combination with gemcitabine in advanced/metastatic epithelial ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2020-12-08Clinical Trial Update: A Study of Oral Rucaparib in Patients With a Solid Tumor (Phase I) or With gBRCA Mutation Ovarian Cancer (Phase II) [Phase 1, Phase 2]
Phase I/II study of oral rucaparib in patients with BRCA-mutant ovarian cancer and to a lesser extent solid tumors; study completed with res…
-
CLINICAL_TRIALS trial_result · 2020-11-30Clinical Trial Update: Tocotrienol as a Nutritional Supplement in Patients With Advanced Ovarian Cancer [Phase 2]
Phase 2 trial assessing tocotrienol as a nutritional supplement in patients with advanced ovarian cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2020-11-25Clinical Trial Update: Anlotinib and Niraparib Dual Therapy Evaluation in Platinum-resistant Recurrent Ovarian Cancer [Phase 2]
Phase 2 clinical trial evaluating dual therapy with Anlotinib and Niraparib for platinum-resistant recurrent ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2020-11-18Clinical Trial Update: Combination Chemotherapy With CS-1008 to Treat Ovarian Cancer [Phase 2]
Phase 2 trial update of CS-1008 in combination chemotherapy for ovarian cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-11-13Clinical Trial Update: Phase Ib/II Study of Carboplatin + M6620 + Avelumab in PARPi-resistant Ovarian Cancer [Phase 1]
Phase Ib/II study of carboplatin plus M6620 and avelumab in PARP inhibitor-resistant ovarian cancer has completed phase 1 with results poste…
-
CLINICAL_TRIALS trial_result · 2020-10-30Clinical Trial Update: Anlotinib Combined With Dose-reduced Olaparib in Patients With Platinum-Sensitive Recurrent Ovarian Cancer [Phase 2]
Phase 2 clinical trial evaluating anlotinib in combination with dose-reduced olaparib for platinum-sensitive recurrent ovarian cancer.
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: Apatinib Combined With Abraxane and Carboplatin or Cisplatinum as First-line Treatment for Epithelial Ovarian Cancer [Phase 2]
Phase 2 trial evaluating apatinib in combination with Abraxane and carboplatin or cisplatin as first-line therapy for epithelial ovarian can…
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: Comparing Two Treatments for Ovarian Cancer: Standard Chemotherapy Plus Enzastaurin, or Placebo ("Sugar Pill") [Phase 2]
Phase 2 trial comparing standard chemotherapy plus enzastaurin versus placebo in ovarian cancer; completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-10-14Clinical Trial Update: Intra-op Detection of Occult Ovarian Carcinoma Using a Folate-Alpha Receptor Specific Fluorescent Ligand [Phase 2]
Phase 2 trial update on intraoperative detection of occult ovarian cancer using a folate-receptor targeted fluorescent ligand; study termina…